Gars1-KO 基因敲除小鼠

1. Megarbane, Andre, Bizzari, Sami, Deepthi, Asha, Delague, Valérie, Urtizberea, J Andoni. . A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort. In Journal of neuromuscular diseases, 9, 193-210. doi:10.3233/JND-210652. https://pubmed.ncbi.nlm.nih.gov/34602496/

2. Markovitz, Rebecca, Ghosh, Rajarshi, Kuo, Molly E, Xiao, Rui, Potocki, Lorraine. 2020. GARS-related disease in infantile spinal muscular atrophy: Implications for diagnosis and treatment. In American journal of medical genetics. Part A, 182, 1167-1176. doi:10.1002/ajmg.a.61544. https://pubmed.ncbi.nlm.nih.gov/32181591/

3. Nie, Jianqiang, Liu, Taobin, Mao, Taotao, Liu, Xiaoqiang, Fu, Bin. 2023. Transcriptome sequencing and single-cell sequencing analysis identify GARS1 as a potential prognostic and immunotherapeutic biomarker for multiple cancers, including bladder cancer. In Frontiers in immunology, 14, 1169588. doi:10.3389/fimmu.2023.1169588. https://pubmed.ncbi.nlm.nih.gov/37404826/

4. Huang, Yufeng, Bi, Bo, Zhao, Peiwei, Liu, Jie, He, Xuelian. 2021. Infantile-onset CMT2D/dSMA-V in a Chinese family with parental germline mosaicism for a novel mutation in the GARS1 gene. In Molecular genetics & genomic medicine, 10, e1846. doi:10.1002/mgg3.1846. https://pubmed.ncbi.nlm.nih.gov/34898052/

5. Jiménez-Jiménez, Jesús, Navarrete, Irene, Azorín, Inmaculada, Sevilla, Teresa, Sivera, Rafael. 2024. Insights into phenotypic variability caused by GARS1 pathogenic variants. In European journal of neurology, 31, e16416. doi:10.1111/ene.16416. https://pubmed.ncbi.nlm.nih.gov/39051710/